ASPIRIN IS PROVEN TO REDUCE THE RISK
OF RECURRENT MI* AND ISCHEMIC STROKE

Studies show that aspirin can reduce the risk of:

Recurrent
myocardial
infarction
by

31% decrease icon

Recurrent
ischemic
stroke
by

22% decrease icon

Discontinuing an aspirin regimen can increase the risk of:

Recurrent
myocardial
infarction
by

63% increase icon

Recurrent
ischemic
stroke
by

40% increase icon

Aspirin plays a critical role in dual antiplatelet therapy

For maximum efficacy, remind patients to continue taking aspirin with their Rx antiplatelet


Aspirin has a
well-established safety profile when used as directed

<1% icon

OF PATIENTS TAKING ASPIRIN FOR SECONDARY PREVENTION
experienced a non-life-threatening GI bleed4†

1.5 icon

DEATHS CAN BE PREVENTED
for every nonfatal GI bleed caused by aspirin use4†

*Nonfatal MI.
†In a meta-analysis of 6300 patients.
References: 1. Antithrombotic Trialists' (ATT) Collaboration. Lancet. 2009;373(9678):1849-1860. 2. Garcia Rodríguez LA, Cea-Soriano L, Martín-Merino E, Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ. 2011;343:d4094. 3. Garcia Rodríguez LA, Cea Soriano L, Hill C, Johansson S. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology. 2011;76(8):740-746. 4. Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002;16(19):2197-2202.